Arca Biopharma reported $-5680000 in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US USD 2.23B 436M
Arca Biopharma ABIO:US USD -5680000 1.58M
Biogen BIIB:US USD 872.1M 68.8M
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Bristol Myers Squibb BMY:US USD 2.32B 418M
Cytokinetics CYTK:US USD -108441000 97.57M
Cytrx CYTR:US USD -1294610 692.11K
Daiichi Sankyo 4568:JP JPY 31.55B 29.65B
Gilead Sciences GILD:US USD 2.27B 565M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Laboratory Of America LH:US USD 484.5M 85.8M
Myriad Genetics MYGN:US USD -45000000 27.2M
Otsuka Holdings 4578:JP JPY 53.07B 6.52B
Pfizer PFE:US USD 5.81B 3.89B
United Therapeutics UTHR:US USD 314.3M 112.5M